ATE140008T1 - Polypeptid - Google Patents

Polypeptid

Info

Publication number
ATE140008T1
ATE140008T1 AT91116065T AT91116065T ATE140008T1 AT E140008 T1 ATE140008 T1 AT E140008T1 AT 91116065 T AT91116065 T AT 91116065T AT 91116065 T AT91116065 T AT 91116065T AT E140008 T1 ATE140008 T1 AT E140008T1
Authority
AT
Austria
Prior art keywords
polypeptide
amino acid
acid sequence
mutein
seq
Prior art date
Application number
AT91116065T
Other languages
English (en)
Inventor
Nobutoshi Yamada
Masanari Kato
Keizo Miyata
Aoyama Yoshiyuki
Hiroshi Shikama
Original Assignee
Ishihara Sangyo Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3240130A external-priority patent/JPH04368397A/ja
Application filed by Ishihara Sangyo Kaisha filed Critical Ishihara Sangyo Kaisha
Application granted granted Critical
Publication of ATE140008T1 publication Critical patent/ATE140008T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91116065T 1990-09-21 1991-09-20 Polypeptid ATE140008T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25004590 1990-09-21
JP3240130A JPH04368397A (ja) 1991-06-17 1991-06-17 ポリペプチド

Publications (1)

Publication Number Publication Date
ATE140008T1 true ATE140008T1 (de) 1996-07-15

Family

ID=26534590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91116065T ATE140008T1 (de) 1990-09-21 1991-09-20 Polypeptid

Country Status (5)

Country Link
US (1) US5247070A (de)
EP (1) EP0479071B1 (de)
JP (1) JPH05255393A (de)
AT (1) ATE140008T1 (de)
DE (1) DE69120626T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5891679A (en) * 1993-02-03 1999-04-06 N.V. Innogenetics S.A. TNF-alpha muteins and a process for preparing them
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
WO1995024501A1 (en) 1994-03-07 1995-09-14 Cetus Oncology Corporation Compositions for the inhibition of tnf formation and uses thereof
EP0740296A3 (de) * 1995-04-26 1998-02-25 Sanyo Electric Co. Ltd Magnetooptische Aufzeichnungsmedium
DE69634044T2 (de) * 1995-10-05 2005-12-08 Sumitomo Electric Industries, Ltd. Menschliches Cyclin I und das dafür codierende Gen
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7244823B2 (en) 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US7687461B2 (en) 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
CA2593648A1 (en) * 2005-01-10 2006-07-13 Research Development Foundation Targeted chimeric molecules for cancer therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677063A (en) * 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
AU1346488A (en) * 1987-02-26 1988-09-26 Cetus Corporation Arginine-depleted human tumor necrosis factor
DE3716513A1 (de) * 1987-05-16 1988-11-24 Basf Ag Proteine mit tnf-wirkung
ATE243754T1 (de) * 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
ATE87007T1 (de) * 1987-05-29 1993-04-15 Sagami Chem Res Fusionsprotein, enthaltend lymphotoxin.

Also Published As

Publication number Publication date
JPH05255393A (ja) 1993-10-05
EP0479071A2 (de) 1992-04-08
DE69120626T2 (de) 1997-01-09
US5247070A (en) 1993-09-21
EP0479071A3 (en) 1993-05-05
EP0479071B1 (de) 1996-07-03
DE69120626D1 (de) 1996-08-08

Similar Documents

Publication Publication Date Title
ATE140008T1 (de) Polypeptid
Thomas et al. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity
Atoda et al. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E
AU704515C (en) Novel protein and process for producing the same
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
CA2641565A1 (en) Nel-related proteins type 1 and 2, and polynucleotides encoding them
EP1197220A3 (de) Therapeutische Verfahren und Zusammensetzungen auf Basis von Delta-Proteinen und Nukleinsäuren
DE69824755D1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
KR950704356A (ko) 선조 b 세포 자극 인자(progenitor b cell stimulating factor)
GR3019043T3 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
DK1396542T3 (da) P-selectin ligand protein
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
DK192189A (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
EP0528686B8 (de) Verfahren zur Herstellung von Peptiden
WO1991011462A3 (en) Merosin, nucleic acids encoding, fragments and uses thereof
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
DE69121227D1 (de) Polypeptid
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
EP0613946A3 (en) Hst-2 mutein, dna coding for the same and preparation thereof.
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
CA1306208C (en) Enhanced expression and stabilization of gene products in microorganisms using short selected leader signal sequences

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties